ALSN
Allison Transmission Holdings, Inc.
ALSN's outlook is improving despite an expensive valuation.
AMZN
Amazon.com, Inc.
AMZN has the edge over ALSN overall, supported by stronger valuation and stronger modeled upside.
ALSN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Under pressure |
ALSN's revenue, profitability and cash flow are currently healthy, but its balance sheet is under pressure.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
ALSN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $57.63 | -54% |
| Fair | 10x | $71.00 | -43% |
| Forward | 12x | $126 | — |
| Expensive | 15x | $102 | -19% |
| Current | 18x | $126 | — |
Historical ranges are pointers, not guarantees.
ALSN's PE is in its expensive range at 18x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over ALSN in the historical PE scenario, which offers more potential upside but is not a forecast.
ALSN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for ALSN, with profitability holding steady. However, they disagree widely on these estimates.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
ALSN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.79 | +55% |
| Q3 2026 | $6.96 | -15% |
| Q2 2026 | $6.29 | -29% |
| Q1 2026 | $6.43 | -26% |
| Q4 2025 | $7.33 | -12% |
| Q3 2025 | $8.16 | -0.1% |
| Q2 2025 | $8.80 | +15% |
| Q1 2025 | $8.64 | +16% |
| Q4 2024 | $8.31 | +12% |
ALSN earned $6.96 per share over the past year, down 15% from the year before.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over ALSN on earnings, with more consistent year-over-year improvement.
ALSN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +121% |
| Q2 2026 | $1.6B | +92% |
| Q1 2026 | $1.4B | +84% |
| Q4 2025 | $737M | -7.4% |
| Q3 2025 | $693M | -16% |
| Q2 2025 | $814M | -0.2% |
| Q1 2025 | $766M | -2.9% |
| Q4 2024 | $796M | +2.7% |
ALSN's revenue has picked up after two years of holding roughly level: $1.5B last quarter, up 121% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -9.6 points |
| Q2 2026 | 19% | -13 points |
| Q1 2026 | 14% | -19 points |
| Q4 2025 | 23% | -6.3 points |
| Q3 2025 | 29% | -2.1 points |
| Q2 2025 | 31% | -0.8 points |
| Q1 2025 | 33% | +2.8 points |
| Q4 2024 | 30% | +0.5 points |
ALSN has the edge over AMZN on profitability, with a higher operating margin.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over ALSN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
ALSN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $278M | +51% |
| Q2 2026 | $281M | +84% |
| Q1 2026 | $103M | -34% |
| Q4 2025 | $169M | +24% |
| Q3 2025 | $184M | -12% |
| Q2 2025 | $153M | +2% |
| Q1 2025 | $155M | -4.3% |
| Q4 2024 | $136M | -27% |
ALSN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
ALSN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -1M shares |
| 1 year | -1.2% | -1M shares |
| 3 years | -7.8% | -7M shares |
| 5 years | -22% | -23M shares |
| Available history | -33% | -40M shares |
ALSN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $57M |
| Q2 2026 | $46M |
| Q1 2026 | $20M |
| Q4 2025 | $46M |
| Q3 2025 | $27M |
| Q2 2025 | $105M |
| Q1 2025 | $150M |
| Q4 2024 | $121M |
ALSN spent $169M buying back its own shares over the past year, down 58% from the year before.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
ALSN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 3.4x | Elevated |
| Q1 2026 | 4.0x | Elevated |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.5x | Healthy |
ALSN's net debt is about 2.8 years of its operating earnings (EBITDA), up from 1.4 years a year ago.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over ALSN on leverage, with a lower net debt burden relative to earnings.
ALSN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 39.8 | Neutral |
ALSN's weekly RSI is 56 (neutral) and its Stochastic is 40 (neutral).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
ALSN PE vs Consumer Cyclical Sector
| Metric | ALSN | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.2% above |
| PE % | 95 | 47 | 48 pts above |
ALSN has the edge over AMZN on valuation relative to its sector.
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
ALSN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.8 | 10% above |
| 20 week MA | $118.6 | 6% above |
| 50 week MA | $116.1 | 8.2% above |
| 100 week MA | $105.7 | 19% above |
| 200 week MA | $87.0 | 44% above |
ALSN is in an uptrend: it's above all five of its weekly moving averages, and 44% above its 200-week average.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
ALSN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.7 | $43.3 | -11% |
| 2021 | $43.3 | $34.6 | -20% |
| 2022 | $34.6 | $42.3 | +22% |
| 2023 | $42.3 | $58.2 | +38% |
| 2024 | $58.2 | $108.7 | +87% |
| 2025 | $108.7 | $100.9 | -7.2% |
| 2026 YTD | $100.9 | $125.7 | +24% |
ALSN has the edge over AMZN on returns for 2026, with the stronger performance.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.